Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis"

SURGELLA: A Scoping Review of Impella-Assisted Hemodynamic Support in High-Risk Non-Cardiac Surgery.

Artificial organs·2026

Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.

Molecular cancer·2026

Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.

Journal of the National Cancer Institute·2026

Negative-pressure wound therapy in thoracic and abdominal surgery: meta-analysis of randomized trials.

BJS open·2026

Outcomes following 2-stage hepatectomy: Systematic review and meta-analysis exploring liver regeneration strategies.

Surgery·2026

Metabolic profiling of steatotic liver disease by fluorescence lifetime imaging microscopy.

Communications medicine·2026

Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

British journal of cancer·2026

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

British journal of cancer·2026

Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus-associated oropharyngeal cancer: a multicentre Phase II trial.

British journal of cancer·2026

Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

British journal of cancer·2026

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

British journal of cancer·2026

Radiomics as a spatial context for treatment decision-making in head and neck cancer.

British journal of cancer·2026

TFAP2B and FOXC1 are associated with biologically and clinically distinct differentiation states in triple-negative breast cancer.

Scientific reports·2026

Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).

Iranian biomedical journal·2026

Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.

Oncogene·2026

Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer.

Oncogene·2026

Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.

Lung cancer (Amsterdam, Netherlands)·2026

Use of extracorporeal membrane oxygenation (ECMO) in Spain as a method of organ preservation for transplantation.

Medicina intensiva·2026

Related Experiment Videos

Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis"

Related Concept Videos

SURGELLA: A Scoping Review of Impella-Assisted Hemodynamic Support in High-Risk Non-Cardiac Surgery.

Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.

Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.

Negative-pressure wound therapy in thoracic and abdominal surgery: meta-analysis of randomized trials.

Outcomes following 2-stage hepatectomy: Systematic review and meta-analysis exploring liver regeneration strategies.

Metabolic profiling of steatotic liver disease by fluorescence lifetime imaging microscopy.

Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus-associated oropharyngeal cancer: a multicentre Phase II trial.

Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

Radiomics as a spatial context for treatment decision-making in head and neck cancer.

TFAP2B and FOXC1 are associated with biologically and clinically distinct differentiation states in triple-negative breast cancer.

Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).

Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.

Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer.

Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.

Use of extracorporeal membrane oxygenation (ECMO) in Spain as a method of organ preservation for transplantation.

Related Experiment Videos

Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis"

Related Concept Videos

Related Articles